2013
Press Releases
-
Researchers Use Web 2.0 Apps to Share Vaccine Study
-
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
-
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
-
Benaroya Research Institute Welcomes New Board Members
-
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
2012
Press Releases
-
New Studies Test Artificial Pancreas for Type 1 Diabetes
-
Twelve Puget Sound Buildings to Turn Blue for World Diabetes Day
-
BRI Receives Grand Challenges Explorations Grant for Groundbreaking Research in Global Health and Development
-
Collaborative Grant Looks for Genetic Roots of Type 1 Diabetes
-
New Grant Awards Aim to Prevent Autoimmune Diseases
-
Pioneering Clinical Trial Studies Efforts to Boost Healthy Immune System
-
Research Reveals Unique Solution to Gene Regulation
-
Benaroya Research Institute Promotes Homer W. Lane Jr. to Executive Director
-
Benaroya Research Institute and Novo Nordisk Collaborate on Autoimmune Disease Research
-
Lynn M. Rose, PhD, Joins BRI as First Director of Scientific Administration
Researchers Use Web 2.0 Apps to Share Vaccine Study
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
Benaroya Research Institute Welcomes New Board Members
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
-
New Studies Test Artificial Pancreas for Type 1 Diabetes
-
Twelve Puget Sound Buildings to Turn Blue for World Diabetes Day
-
BRI Receives Grand Challenges Explorations Grant for Groundbreaking Research in Global Health and Development
-
Collaborative Grant Looks for Genetic Roots of Type 1 Diabetes
-
New Grant Awards Aim to Prevent Autoimmune Diseases
-
Pioneering Clinical Trial Studies Efforts to Boost Healthy Immune System
-
Research Reveals Unique Solution to Gene Regulation
-
Benaroya Research Institute Promotes Homer W. Lane Jr. to Executive Director
-
Benaroya Research Institute and Novo Nordisk Collaborate on Autoimmune Disease Research
-
Lynn M. Rose, PhD, Joins BRI as First Director of Scientific Administration
